ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME
- 23 February 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8426), 450-451
- https://doi.org/10.1016/s0140-6736(85)91162-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTESThe Lancet, 1984
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDSThe Lancet, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- The antiviral compound HPA-23 can prevent scrapie when administered at the time of infectionArchiv für die gesamte Virusforschung, 1983
- Effect of Ammonium 5-Tungsto-2-Antimoniate on Encephalomyocarditis and Vesicular Stomatitis Virus Infections in MiceJournal of General Virology, 1976
- Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniateBiochemical and Biophysical Research Communications, 1975
- In Vivo Inhibition of Murine Leukemia and Sarcoma Viruses by the Heteropolyanion 5-Tungsto-2-antimoniate2JNCI Journal of the National Cancer Institute, 1974